No Record Found
Sector
PharmaceuticalsOpen
₹7.09Prev. Close
₹6.96Turnover(Lac.)
₹1.7Day's High
₹7.09Day's Low
₹7.0952 Week's High
₹6.9652 Week's Low
₹2.97Book Value
₹16.86Face Value
₹10Mkt Cap (₹ Cr.)
17.72P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 23.36 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 36.82 | 36.43 | 35.35 | 36.51 | 
| Net Worth | 61.82 | 61.43 | 60.35 | 59.87 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
| Revenue | 72.38 | 57.04 | 62.44 | 59.41 | 
| yoy growth (%) | 26.88 | -8.64 | 5.09 | 14.74 | 
| Raw materials | -42.91 | -33.6 | -40.42 | -36.01 | 
| As % of sales | 59.28 | 58.9 | 64.73 | 60.61 | 
| Employee costs | -6.92 | -4.59 | -5.62 | -4.29 | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
| Profit before tax | 0.86 | 0.07 | 1.07 | 5.26 | 
| Depreciation | -2.45 | -2.45 | -2.92 | -1.94 | 
| Tax paid | -0.33 | -0.14 | -0.28 | -1.25 | 
| Working capital | 4.97 | -5.1 | -0.87 | 14.24 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 26.88 | -8.64 | 5.09 | 14.74 | 
| Op profit growth | 23.63 | -7.39 | -37.21 | 30.48 | 
| EBIT growth | 20.24 | -4.71 | -44.86 | 38.9 | 
| Net profit growth | -551.24 | -111.05 | -83.64 | 79.07 | 
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | 
|---|---|---|---|---|---|
| Gross Sales | 61.7 | 68.59 | 77.87 | 73.73 | 57.09 | 
| Excise Duty | 0 | 0 | 0 | 0 | 0 | 
| Net Sales | 61.7 | 68.59 | 77.87 | 73.73 | 57.09 | 
| Other Operating Income | 0 | 0 | 0 | 0 | 0 | 
| Other Income | 0.44 | 0.73 | 0.54 | 0.28 | 0.86 | 
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.6 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,653.65 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.5 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,600.9 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,445.75 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Suraj Zanwar
Independent Director
Sunil Kumar
Whole Time Director
Santosh Pimparkar
Milkat No 3339 BNo 1 Phursungi,
From Southside CS NO 227/2,
Maharashtra - 412308
Tel: 91-020-26982792
Website: http://www.cian.co
Email: cs@cian.co
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of Cian Healthcare Private Limited on January 07, 2003. Subsequently, the Company was converted into a Pu...
Read More
Reports by Cian Healthcare Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.